Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (NYSE:HIMS)

This article was written by Follow I’m a retired Wall Street PM specializing in TMT; since…

Hims & Hers: Reaching Escape Velocity Goes Unnoticed By The Market (NYSE:HIMS)

This article was written by Follow Investor based in Geneva, Switzerland. Follow me on Twitter @GenevaInvestor…

Hims & Hers: AI-Powered Healthcare Disruption (NYSE:HIMS)

This article was written by Follow Pythia Research focuses on multi-bagger stocks, primarily in the technology…

Hims & Hers Declines – How The GLP-1 Market Shift Affects Growth (NYSE:HIMS)

This article was written by Follow After working as a Registered Nurse for several years, I…

Hims & Hers Stock: Ready To Outperform Further (NYSE:HIMS)

This article was written by Follow As an investor who started my path five years ago…

Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS)

This article was written by Follow Stone Fox Capital (aka Mark Holder) is a CPA with…

Don’t Buy Hims & Hers Stock If You Want Better Than Mediocre Returns (NYSE:HIMS)

This article was written by Follow Oliver Rodzianko is an investment analyst specializing in the technology…